1.0Najafi Capital Deal Making Platformhttps://najafi.capital/pladminhttps://najafi.capital/pl/author/admin/rich600338<blockquote class="wp-embedded-content" data-secret="3BWruGnZ8i"><a href="https://najafi.capital/pl/individual-investor/individual-angel-oliver-friedrichs/">#ERROR!</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://najafi.capital/pl/individual-investor/individual-angel-oliver-friedrichs/embed/#?secret=3BWruGnZ8i" width="600" height="338" title="„Individual/Angel: Oliver Friedrichs” — Najafi Capital Deal Making Platform" data-secret="3BWruGnZ8i" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://najafi.capital/wp-includes/js/wp-embed.min.js </script>Oliver Friedrichs is founder and CEO of Immunet. Prior to Immunet, Oliver spent six years at Symantec, the producers of Norton AntiVirus, serving as Director, Emerging Technologies. In this role he managed Symantec Advanced Threat Research and oversaw the delivery of new technologies to automate the generation of AntiVirus detections. Oliver served as co-founder at […]